Cover Page
Cover Page - shares | 6 Months Ended | |
Jun. 30, 2022 | Jul. 27, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-36468 | |
Entity Registrant Name | Arista Networks, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 20-1751121 | |
Entity Address, Address Line One | 5453 Great America Parkway | |
Entity Address, City or Town | Santa Clara | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 95054 | |
City Area Code | (408) | |
Local Phone Number | 547-5500 | |
Title of 12(b) Security | Common Stock, $0.0001 par value | |
Trading Symbol | ANET | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding (in shares) | 304,280,458 | |
Entity Central Index Key | 0001596532 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2022 | Dec. 31, 2021 |
CURRENT ASSETS: | ||
Cash and cash equivalents | $ 493,246 | $ 620,813 |
Marketable securities | 2,408,656 | 2,787,502 |
Accounts receivable, net | 585,786 | 516,509 |
Inventories | 852,810 | 650,117 |
Prepaid expenses and other current assets | 388,697 | 237,735 |
Total current assets | 4,729,195 | 4,812,676 |
Property and equipment, net | 91,823 | 78,634 |
Acquisition-related intangible assets, net | 140,836 | 93,555 |
Goodwill | 273,494 | 188,397 |
Investments | 38,263 | 20,247 |
Operating lease right-of-use assets | 61,869 | 65,182 |
Deferred tax assets | 442,455 | 442,295 |
Other assets | 46,610 | 33,443 |
TOTAL ASSETS | 5,824,545 | 5,734,429 |
CURRENT LIABILITIES: | ||
Accounts payable | 275,093 | 202,636 |
Accrued liabilities | 210,334 | 226,643 |
Deferred revenue | 697,762 | 593,578 |
Other current liabilities | 94,837 | 86,972 |
Total current liabilities | 1,278,026 | 1,109,829 |
Income taxes payable | 79,422 | 69,916 |
Operating lease liabilities, non-current | 51,793 | 56,527 |
Deferred revenue, non-current | 335,728 | 335,734 |
Deferred tax liabilities, non-current | 13,447 | 129,074 |
Other long-term liabilities | 60,337 | 54,749 |
TOTAL LIABILITIES | 1,818,753 | 1,755,829 |
Commitments and contingencies (Note 5) | ||
STOCKHOLDERS’ EQUITY: | ||
Preferred stock, $0.0001 par value—100,000 shares authorized and no shares issued and outstanding as of June 30, 2022 and December 31, 2021 | 0 | 0 |
Common stock, $0.0001 par value—1,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 304,455 and 307,681 shares issued and outstanding as of June 30, 2022 and December 31, 2021 | 30 | 31 |
Additional paid-in capital | 1,638,787 | 1,530,046 |
Retained earnings | 2,408,294 | 2,456,823 |
Accumulated other comprehensive income (loss) | (41,319) | (8,300) |
TOTAL STOCKHOLDERS’ EQUITY | 4,005,792 | 3,978,600 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 5,824,545 | $ 5,734,429 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Jun. 30, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 1,000,000,000 | 1,000,000,000 |
Common stock, shares issued (in shares) | 304,455,000 | 307,681,000 |
Common stock, shares outstanding (in shares) | 304,455,000 | 307,681,000 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | ||
Revenue: | |||||
Total revenue | $ 1,051,891 | $ 707,319 | $ 1,928,957 | $ 1,374,881 | |
Cost of revenue: | |||||
Total cost of revenue | 408,626 | 253,141 | 731,847 | 495,431 | |
Gross profit | 643,265 | 454,178 | 1,197,110 | 879,450 | |
Operating expenses: | |||||
Research and development | 178,158 | 143,293 | 350,164 | 275,780 | |
Sales and marketing | 79,372 | 70,625 | 160,111 | 141,645 | |
General and administrative | 22,882 | 20,895 | 45,995 | 36,368 | |
Total operating expenses | 280,412 | 234,813 | 556,270 | 453,793 | |
Income from operations | 362,853 | 219,365 | 640,840 | 425,657 | |
Other income (expense), net | (533) | 1,719 | 30,947 | 3,294 | |
Income before income taxes | 362,320 | 221,084 | 671,787 | 428,951 | |
Provision for income taxes | 63,221 | 24,196 | 100,429 | 51,697 | |
Net income | $ 299,099 | $ 196,888 | $ 571,358 | $ 377,254 | |
Net income per share | |||||
Basic (in dollars per share) | [1] | $ 0.98 | $ 0.64 | $ 1.86 | $ 1.23 |
Diluted (in dollars per share) | [1] | $ 0.94 | $ 0.62 | $ 1.80 | $ 1.18 |
Weighted-average shares used in computing net income per share | |||||
Basic (in shares) | [1] | 306,754 | 305,844 | 307,399 | 305,536 |
Diluted (in shares) | [1] | 316,581 | 318,840 | 318,040 | 318,708 |
Product | |||||
Revenue: | |||||
Total revenue | $ 885,806 | $ 566,467 | $ 1,610,524 | $ 1,105,612 | |
Cost of revenue: | |||||
Total cost of revenue | 375,634 | 225,779 | 669,443 | 444,212 | |
Service | |||||
Revenue: | |||||
Total revenue | 166,085 | 140,852 | 318,433 | 269,269 | |
Cost of revenue: | |||||
Total cost of revenue | $ 32,992 | $ 27,362 | $ 62,404 | $ 51,219 | |
[1]Prior periods have been adjusted to reflect the four-for-one stock split effected in the form of a stock dividend in November 2021. |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Operations (Parenthetical) | 1 Months Ended |
Nov. 30, 2021 | |
Income Statement [Abstract] | |
Stock split ratio | 4 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 299,099 | $ 196,888 | $ 571,358 | $ 377,254 |
Other comprehensive income (loss), net of tax: | ||||
Foreign currency translation adjustments | (2,359) | 191 | (2,732) | (350) |
Net change in unrealized gains (losses) on available-for-sale securities | (8,459) | (466) | (30,287) | (1,027) |
Other comprehensive income (loss) | (10,818) | (275) | (33,019) | (1,377) |
Comprehensive income | $ 288,281 | $ 196,613 | $ 538,339 | $ 375,877 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | |||
Beginning balance (in shares) at Dec. 31, 2020 | [1] | 304,696 | ||||||
Beginning balance at Dec. 31, 2020 | $ 3,320,291 | $ 30 | [1] | $ 1,292,409 | [1] | $ 2,027,614 | $ 238 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net income | 377,254 | 377,254 | ||||||
Other comprehensive loss, net of tax | (1,377) | (1,377) | ||||||
Stock-based compensation | 82,497 | 82,497 | [1] | |||||
Issuance of common stock in connection with employee equity incentive plans (in shares) | [1] | 3,512 | ||||||
Issuance of common stock in connection with employee equity incentive plans | 26,884 | 26,884 | [1] | |||||
Repurchase of common stock (in shares) | [1] | (1,468) | ||||||
Repurchase of common stock | (101,355) | (101,355) | ||||||
Tax withholding paid for net share settlement of equity awards (in shares) | [1] | (80) | ||||||
Tax withholding paid for net share settlement of equity awards | (6,353) | (6,353) | [1] | |||||
Ending balance (in shares) at Jun. 30, 2021 | [1] | 306,660 | ||||||
Ending balance at Jun. 30, 2021 | 3,697,841 | $ 30 | [1] | 1,395,437 | [1] | 2,303,513 | (1,139) | |
Beginning balance (in shares) at Mar. 31, 2021 | [1] | 305,028 | ||||||
Beginning balance at Mar. 31, 2021 | 3,451,338 | $ 30 | [1] | 1,345,547 | [1] | 2,106,625 | (864) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net income | 196,888 | 196,888 | ||||||
Other comprehensive loss, net of tax | (275) | (275) | ||||||
Stock-based compensation | 44,944 | 44,944 | [1] | |||||
Issuance of common stock in connection with employee equity incentive plans (in shares) | [1] | 1,676 | ||||||
Issuance of common stock in connection with employee equity incentive plans | 8,803 | 8,803 | [1] | |||||
Tax withholding paid for net share settlement of equity awards (in shares) | [1] | (44) | ||||||
Tax withholding paid for net share settlement of equity awards | (3,857) | (3,857) | [1] | |||||
Ending balance (in shares) at Jun. 30, 2021 | [1] | 306,660 | ||||||
Ending balance at Jun. 30, 2021 | 3,697,841 | $ 30 | [1] | 1,395,437 | [1] | 2,303,513 | (1,139) | |
Beginning balance (in shares) at Dec. 31, 2021 | 307,681 | |||||||
Beginning balance at Dec. 31, 2021 | 3,978,600 | $ 31 | 1,530,046 | 2,456,823 | (8,300) | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net income | 571,358 | 571,358 | ||||||
Other comprehensive loss, net of tax | (33,019) | (33,019) | ||||||
Stock-based compensation | 100,503 | 100,503 | ||||||
Issuance of common stock in connection with employee equity incentive plans (in shares) | 2,858 | |||||||
Issuance of common stock in connection with employee equity incentive plans | $ 22,991 | 22,991 | ||||||
Repurchase of common stock (in shares) | (5,954) | (5,954) | ||||||
Repurchase of common stock | $ (619,888) | $ (1) | (619,887) | |||||
Tax withholding paid for net share settlement of equity awards (in shares) | (163) | |||||||
Tax withholding paid for net share settlement of equity awards | (18,802) | (18,802) | ||||||
Common stock issued for business acquisition (in shares) | 33 | |||||||
Common stock issued for business acquisition | 4,049 | 4,049 | ||||||
Ending balance (in shares) at Jun. 30, 2022 | 304,455 | |||||||
Ending balance at Jun. 30, 2022 | 4,005,792 | $ 30 | 1,638,787 | 2,408,294 | (41,319) | |||
Beginning balance (in shares) at Mar. 31, 2022 | 308,165 | |||||||
Beginning balance at Mar. 31, 2022 | 4,153,177 | $ 31 | 1,590,793 | 2,592,854 | (30,501) | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||
Net income | 299,099 | 299,099 | ||||||
Other comprehensive loss, net of tax | (10,818) | (10,818) | ||||||
Stock-based compensation | 50,224 | 50,224 | ||||||
Issuance of common stock in connection with employee equity incentive plans (in shares) | 1,131 | |||||||
Issuance of common stock in connection with employee equity incentive plans | 3,831 | 3,831 | ||||||
Repurchase of common stock (in shares) | (4,783) | |||||||
Repurchase of common stock | (483,660) | $ (1) | (483,659) | |||||
Tax withholding paid for net share settlement of equity awards (in shares) | (58) | |||||||
Tax withholding paid for net share settlement of equity awards | (6,061) | (6,061) | ||||||
Ending balance (in shares) at Jun. 30, 2022 | 304,455 | |||||||
Ending balance at Jun. 30, 2022 | $ 4,005,792 | $ 30 | $ 1,638,787 | $ 2,408,294 | $ (41,319) | |||
[1]Prior periods have been adjusted to reflect the four-for-one stock split effected in the form of a stock dividend in November 2021. |
Condensed Consolidated Statem_5
Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) | 1 Months Ended |
Nov. 30, 2021 | |
Statement of Stockholders' Equity [Abstract] | |
Stock split ratio | 4 |
Condensed Consolidated Statem_6
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2022 | Jun. 30, 2021 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net income | $ 571,358 | $ 377,254 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation, amortization and other | 28,012 | 25,235 |
Stock-based compensation | 100,503 | 82,497 |
Noncash lease expense | 9,161 | 8,410 |
Deferred income taxes | (105,937) | (2,998) |
Unrealized gain on equity investments | (23,413) | 0 |
Amortization of investment premiums | 11,457 | 12,121 |
Changes in operating assets and liabilities: | ||
Accounts receivable, net | (64,335) | 25,326 |
Inventories | (202,052) | (63,531) |
Prepaid expenses and other current assets | (158,149) | (44,356) |
Other assets | (5,543) | (3,390) |
Accounts payable | 71,169 | 10,879 |
Accrued liabilities | (16,210) | 20,025 |
Deferred revenue | 91,201 | 95,263 |
Income taxes payable | 10,792 | (9,144) |
Other liabilities | 221 | (15,550) |
Net cash provided by operating activities | 318,235 | 518,041 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Proceeds from maturities of marketable securities | 829,714 | 819,807 |
Purchases of marketable securities | (641,979) | (1,241,657) |
Purchases of property and equipment | (23,744) | (9,567) |
Business acquisitions, net of cash acquired | (145,087) | 1,419 |
Investments in privately-held companies and intangibles | (11,691) | (6,084) |
Proceeds from sale of marketable securities | 165,746 | 0 |
Net cash provided by (used in) investing activities | 172,959 | (436,082) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from issuance of common stock under equity plans | 22,991 | 26,884 |
Tax withholding paid on behalf of employees for net share settlement | (18,802) | (6,353) |
Repurchase of common stock | (619,888) | (101,355) |
Net cash used in financing activities | (615,699) | (80,824) |
Effect of exchange rate changes | (3,041) | (665) |
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (127,546) | 470 |
CASH, CASH EQUIVALENTS AND RESTRICTED CASH —Beginning of period | 625,050 | 897,454 |
CASH, CASH EQUIVALENTS AND RESTRICTED CASH —End of period | 497,504 | 897,924 |
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION: | ||
Right-of-use assets obtained in exchange for new operating lease liabilities | 6,022 | 1,619 |
Property and equipment included in accounts payable and accrued liabilities | 4,520 | 1,732 |
Common stock issued for business acquisition | $ 4,049 | $ 0 |
Organization and Summary of Sig
Organization and Summary of Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2022 | |
Accounting Policies [Abstract] | |
Organization and Summary of Significant Accounting Policies | Organization and Summary of Significant Accounting Policies Organization Arista Networks, Inc. (together with our subsidiaries, “we,” “our,” "Arista," "Company" or “us”) is a supplier of cloud networking solutions that use software innovations to address the needs of large-scale internet companies, cloud service providers and next-generation enterprises. Our cloud networking solutions consist of our Extensible Operating System ("EOS"), a set of network applications and our Gigabit Ethernet switching and routing platforms. We are incorporated in the state of Delaware. Our corporate headquarters are located in Santa Clara, California, and we have wholly-owned subsidiaries throughout the world, including North America, Europe, Asia and Australia. Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Arista Networks, Inc. and its wholly-owned subsidiaries and have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and the requirements of the U.S. Securities and Exchange Commission (the “SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP can be condensed or omitted. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments, which include only normal recurring adjustments, necessary for the fair presentation of our financial information. The results for the three and six months ended June 30, 2022, are not necessarily indicative of the results expected for the full fiscal year. The condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited consolidated financial statements at that date but does not include all of the information and notes required by GAAP for complete financial statements. All significant inter-company accounts and transactions have been eliminated. Our condensed consolidated financial statements and related financial information in this Quarterly Report on Form 10-Q should be read in conjunction with the audited consolidated financial statements and related footnotes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on February 15, 2022. Use of Estimates The preparation of the accompanying consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Those estimates and assumptions include, but are not limited to, valuation of inventory and contract manufacturer/supplier liabilities, accounting for income taxes, including the recognition of deferred tax assets and liabilities, valuation allowance on deferred tax assets and reserves for uncertain tax positions, revenue recognition and deferred revenue, allowance for doubtful accounts, sales rebates and return reserves, valuation of goodwill and acquisition-related intangible assets, estimate of useful lives of long-lived assets including intangible assets, and the recognition and measurement of contingent liabilities. We evaluate our estimates and assumptions based on historical experience and other factors and adjust these estimates and assumptions when facts and circumstances dictate. Actual results could differ materially from these estimates. Risks and Uncertainties Global economic and business activities continue to face widespread macroeconomic uncertainties, including supply chain and labor shortages, inflation and monetary policy shifts, recession risks, the ongoing global coronavirus ("COVID-19") pandemic and potential disruptions from the Russia-Ukraine conflict. Our contract manufacturers and suppliers have experienced workforce disruptions, delays in component sourcing, production and export of their products as well as component shortages and increased component costs, which have disrupted our supply chain and have impacted and will likely continue to impact our ability to supply products to our customers on a timely basis. While we continue to experience strong overall demand from customers, we believe ongoing supply disruptions combined with other supply chain related constraints could impact our ability to fulfill this increased demand and as a result could negatively impact our business in future periods. In addition, inflation pressure in our supply chain and scarcity of some materials needed to build our products have increased our cost of revenue and have impacted, and may continue to negatively impact our gross margin. The extent of the impact on our operational and financial performance, including our ability to execute our business strategies and initiatives in the expected time frame, and the impact of any initiatives and programs we may undertake to address financial and operational challenges, will depend on future developments, the impact to our customers, partners, employees, contract manufacturers and supply chain, as well as restrictions on travel and transport, all of which continue to evolve and are unpredictable. Management continues to actively monitor the impact of these macroeconomic factors on the Company's financial condition, liquidity, operations, suppliers, industry, and workforce. As of the date of issuance of these condensed consolidated financial statements, the extent to which these factors may materially impact the Company's financial condition, liquidity, or results of operations is uncertain. Recently Adopted Accounting Pronouncements In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. ASU 2021-08 requires companies to recognize and measure contract assets and contract liabilities relating to contracts with customers that are acquired in a business combination in accordance with ASC 606. Under previous GAAP, an acquirer generally recognizes assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. ASU No. 2021-08 results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC Topic 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company adopted this ASU as of January 1, 2022 on a prospective basis and the adoption impact was immaterial to the condensed consolidated financial statements. The standard will not impact acquired contract assets or liabilities from business combinations occurring prior to the adoption date. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jun. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Assets measured at fair values on a recurring basis We measure and report our cash equivalents, restricted cash, marketable equity securities and available-for-sale debt securities at fair value on a recurring basis. The following tables summarize the fair value of these financial assets by significant investment category and their levels within the fair value hierarchy (in thousands): As of June 30, 2022 As of December 31, 2021 Level I Level II Level III Total Level I Level II Level III Total Financial Assets: Cash Equivalents: Money market funds $ 274,754 $ — $ — $ 274,754 $ 221,382 $ — $ — $ 221,382 Commercial paper — 3,642 — 3,642 — — — — 274,754 3,642 — 278,396 221,382 — — 221,382 Marketable Securities: Commercial paper — 18,462 — 18,462 — 141,274 — 141,274 Certificate of deposits (1) — 13,030 — 13,030 — 44,931 — 44,931 U.S. government notes 1,082,084 — — 1,082,084 1,057,810 — — 1,057,810 Corporate bonds — 1,066,585 — 1,066,585 — 1,252,226 — 1,252,226 Agency securities — 211,768 — 211,768 — 291,261 — 291,261 Marketable equity securities (2) 16,727 — — 16,727 — — — — 1,098,811 1,309,845 — 2,408,656 1,057,810 1,729,692 — 2,787,502 Other Assets: Money market funds - restricted 4,258 — — 4,258 4,237 — — 4,237 Total Financial Assets $ 1,377,823 $ 1,313,487 $ — $ 2,691,310 $ 1,283,429 $ 1,729,692 $ — $ 3,013,121 ______________________________________ (1) As of June 30, 2022 and December 31, 2021, all of our certificates of deposits were domestic deposits. (2) The $16.7 million represents the fair value of marketable equity securities as of June 30, 2022. This amount includes $8.3 million that was reclassified from Investments on our condensed consolidated balance sheet following the commencement of public market trading of the issuer in January 2022. This publicly-traded equity investment generated an unrealized gain of $8.4 million for the six months ended June 30, 2022, and an unrealized loss of $5.1 million for the three months ended June 30, 2022. The unrealized gains and losses are included in Other income (expense), net on the Condensed Consolidated Statements of Operations. Refer to Note 3. Financial Statements Details. During the three and six months ended on June 30, 2022, the Company did not make any transfers between the levels of the fair value hierarchy. Marketable debt securities The following table summarizes the amortized cost, unrealized gains and losses, and fair value of our debt securities measured at fair value on a recurring basis (in thousands): As of June 30, 2022 As of December 31, 2021 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Amortized Cost Unrealized Gains Unrealized Losses Fair Value Commercial paper $ 18,462 $ — $ — $ 18,462 $ 141,274 $ — $ — $ 141,274 U.S. government 1,098,360 — (16,276) 1,082,084 1,060,716 3 (2,909) 1,057,810 Corporate bonds 1,083,803 6 (17,224) 1,066,585 1,255,149 105 (3,028) 1,252,226 Agency securities 214,687 1 (2,920) 211,768 291,558 36 (333) 291,261 Total $ 2,415,312 $ 7 $ (36,420) $ 2,378,899 $ 2,748,697 $ 144 $ (6,270) $ 2,742,571 For debt securities in unrealized loss positions, it is not likely that we will be required to sell such securities before recovery of their amortized cost basis nor do we have the intent to sell such securities before maturity; we invest in debt securities that have maximum maturities of two years and are generally deemed to be low risk based on their credit ratings from the major rating agencies. The longer the duration of these marketable securities, the more susceptible they are to changes in market interest rates and bond yields. Given the short-term and conservative nature of our portfolio, the unrealized losses are not related to credit risk; therefore, we did not recognize any credit losses or non-credit-related impairments related to our available-for-sale marketable debt securities for the three and six months ended June 30, 2022. All unrealized losses were recognized in other comprehensive income (loss). Realized losses were immaterial for the three and six months ended June 30, 2022. The following table is an analysis of our marketable debt securities in unrealized loss positions (in thousands): As of June 30, 2022 Unrealized Losses within 12 months Unrealized Losses 12 months or greater Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. government notes $ 1,082,084 $ (16,276) $ — $ — $ 1,082,084 $ (16,276) Corporate bonds 995,771 (16,075) 65,373 (1,149) 1,061,144 (17,224) Agency securities 206,768 (2,920) — — 206,768 (2,920) Total $ 2,284,623 $ (35,271) $ 65,373 $ (1,149) $ 2,349,996 $ (36,420) As of June 30, 2022, we had no marketable debt securities with contractual maturities that exceed 24 months. The fair values of marketable debt securities, by remaining contractual maturities, are as follows (in thousands): As of June 30, 2022 Fair Value Due in 1 year or less $ 1,700,701 Due in 1 to 2 years 678,198 Total debt securities $ 2,378,899 The weighted-average remaining duration of our marketable debt securities is approximately 0.8 years as of June 30, 2022. As we view these marketable debt securities as available to support current operations, we classify marketable debt securities with maturities beyond 12 months as current assets under the caption "Marketable securities" on the condensed consolidated balance sheets. Assets measured at fair value on a non-recurring basis Non-Marketable Equity Securities We have non-marketable equity securities in privately-held companies that do not have readily-determinable fair values. These equity securities are included in Investments on the condensed consolidated balance sheets. Their initial cost is adjusted to fair value on a non-recurring basis based on observable price changes from orderly transactions of identical or similar securities of the same issuer, or for impairment. These investments are classified within Level III of the fair value hierarchy as we estimate the value based on valuation methods using the observable transaction price at the transaction date and other significant unobservable inputs, such as volatility, rights, and obligations related to these securities. In addition, the valuation requires management judgment due to the absence of market price and lack of liquidity. We did not record any realized gains or losses for our non-marketable equity securities measured at fair value on a non-recurring basis during the three and six months ended June 30, 2022 and June 30, 2021. We recorded an unrealized gain of $15.0 million on non-marketable equity securities based on observable price changes from orderly transactions of identical or similar securities of the same issuer in the six months ended June 30, 2022, but did not record any unrealized losses or additional unrealized gains in the three months ended June 30, 2022 and the three and six months ended June 30, 2021. We evaluate our non-marketable equity securities for impairment at each reporting period via a qualitative assessment with various potential impairment indicators, including, but not limited to, an assessment of a significant adverse change in the economic environment, significant adverse changes in the general market condition of the geographies and industries in which our investees operate, and other publicly-available information that affected the value of the its non-marketable equity securities. The following table summarizes the activity related to our non-marketable equity securities as of June 30, 2022 and December 31, 2021 (in thousands): June 30, 2022 December 31, 2021 Cost of investments (1) $ 23,263 $ 14,933 Cumulative impairment — — Cumulative upward adjustment (1) 15,000 5,314 Carrying amount of investments $ 38,263 $ 20,247 |
Financial Statements Details
Financial Statements Details | 6 Months Ended |
Jun. 30, 2022 | |
Balance Sheet Components [Abstract] | |
Financial Statements Details | Financial Statements Details Cash, Cash Equivalents and Restricted Cash The reconciliation of cash, cash equivalents and restricted cash reported on the unaudited condensed consolidated balance sheets to the total of the same such amounts in the unaudited condensed consolidated statements of cash flows is as follows (in thousands): June 30, 2022 December 31, 2021 Cash and cash equivalents $ 493,246 $ 620,813 Restricted cash included in other assets 4,258 4,237 Total cash, cash equivalents and restricted cash $ 497,504 $ 625,050 Accounts Receivable, net Accounts receivable, net consists of the following (in thousands): June 30, 2022 December 31, 2021 Accounts receivable $ 598,380 $ 521,597 Allowance for doubtful accounts (207) (132) Product sales rebate and returns reserve (12,387) (4,956) Accounts receivable, net $ 585,786 $ 516,509 Inventories Inventories consist of the following (in thousands): June 30, 2022 December 31, 2021 Raw materials $ 462,396 $ 316,737 Finished goods 390,414 333,380 Total inventories $ 852,810 $ 650,117 Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following (in thousands): June 30, 2022 December 31, 2021 Inventory deposits $ 98,099 $ 46,311 Prepaid income taxes 10,189 8,977 Other current assets 256,102 163,916 Other prepaid expenses and deposits 24,307 18,531 Total prepaid expenses and other current assets $ 388,697 $ 237,735 Property and Equipment, net Property and equipment, net consists of the following (in thousands): June 30, 2022 December 31, 2021 Land $ 40,485 $ 40,145 Equipment and machinery 111,646 90,915 Computer hardware and software 47,376 44,083 Leasehold improvements 30,208 30,502 Furniture and fixtures 3,612 3,634 Construction-in-process 2,207 2,378 Property and equipment, gross 235,534 211,657 Less: accumulated depreciation (143,711) (133,023) Property and equipment, net $ 91,823 $ 78,634 Depreciation expense was $6.2 million and $4.8 million for the three months ended June 30, 2022 and 2021, respectively, and $11.8 million and $9.7 million for the six months ended June 30, 2022 and 2021, respectively. Accrued Liabilities Accrued liabilities consist of the following (in thousands): June 30, 2022 December 31, 2021 Accrued payroll related costs $ 78,066 $ 99,571 Accrued manufacturing costs 79,949 80,213 Accrued product development costs 24,311 22,188 Accrued warranty costs 13,288 10,414 Other 14,720 14,257 Total accrued liabilities $ 210,334 $ 226,643 Warranty Accrual The following table summarizes the activity related to our accrued liability for estimated future warranty costs (in thousands): Six Months Ended June 30, 2022 2021 Warranty accrual, beginning of period $ 10,414 $ 9,314 Liabilities accrued for warranties issued during the period 8,441 5,603 Warranty costs incurred during the period (5,567) (5,922) Warranty accrual, end of period $ 13,288 $ 8,995 Contract Assets The following table summarizes the beginning and ending balances of our contract assets included in "Prepaid and other current assets" on the condensed consolidated balance sheets (in thousands): Six Months Ended June 30, 2022 Contract assets, beginning balance $ 24,388 Contract assets, ending balance 29,237 Contract Liabilities, Deferred Revenue and Other Performance Obligations Contract Liabilities A contract liability is recognized when we have received customer payments in advance of our satisfaction of a performance obligation under a cancellable contract. The following table summarizes the activity related to our contract liabilities (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Contract liabilities, beginning balance $ 98,422 $ 80,465 $ 93,382 $ 85,957 Less: Revenue recognized from beginning balance (8,589) (8,482) (19,076) (18,482) Less: Beginning balance reclassified to deferred revenue (4,338) (3,856) (3,606) (12,710) Add: Contract liabilities recognized 16,105 15,227 30,900 28,589 Contract liabilities, ending balance $ 101,600 $ 83,354 $ 101,600 $ 83,354 As of June 30, 2022 and December 31, 2021, $41.4 million and $38.7 million of our contract liabilities, respectively, were included in "Other current liabilities" with the remaining balances included in "Other long-term liabilities" on the condensed consolidated balance sheets. Deferred Revenue Deferred revenue is comprised mainly of unearned revenue related to multi-year post-contract support ("PCS") contracts, services and product deferrals related to acceptance clauses. The following table summarizes the activity related to our deferred revenue (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Deferred revenue, beginning balance $ 1,123,746 $ 720,031 $ 929,312 $ 650,827 Less: Revenue recognized from beginning balance (309,594) (145,556) (322,954) (222,865) Add: Deferral of revenue in current period, excluding amounts recognized during the period 219,338 171,615 427,132 318,128 Deferred revenue, ending balance $ 1,033,490 $ 746,090 $ 1,033,490 $ 746,090 Other Performance Obligations Other performance obligations include unbilled contract revenue for services and products that will be recognized in future periods. As of June 30, 2022, other performance obligations of $178.1 million were comprised mainly of unbilled multi-year PCS contract amounts that will be recognized as revenue in future periods. In addition, as of June 30, 2022 the company had entered into $762.7 million of binding contractual agreements with certain customers that are primarily related to future product shipments. Revenue from Total Remaining Performance Obligations Revenue from total remaining performance obligations represents contract liabilities, deferred revenue and unbilled contract revenue that will be recognized in future periods. As of June 30, 2022, approximately $1,313.3 million of revenue is expected to be recognized from remaining performance obligations, of which approximately 83% is expected to be recognized over the next two years and approximately 17% is expected to be recognized during the third to the fifth year. These amounts do not include the $762.7 million of binding contractual agreements related primarily to future product shipments outlined above. As of June 30, 2022, it is expected that the majority of the amounts allocated to these specific performance obligations will be recognized as revenue upon product shipment over the next two years; however, given the current uncertain supply chain environment and industry wide supply constraints, we may experience manufacturing and shipment delays or cancellations related to these performance obligations, which could impact revenue recognition. Other Income (Expense), net Other income (expense), net consists of the following (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Interest income $ 4,427 $ 1,872 $ 6,855 $ 3,917 Unrealized gain (loss) on equity investments (5,084) — 23,413 — Other income (expense), net 124 (153) 679 (623) Total $ (533) $ 1,719 $ 30,947 $ 3,294 |
Acquisition, Goodwill and Acqui
Acquisition, Goodwill and Acquisition-Related Intangible Assets | 6 Months Ended |
Jun. 30, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisition, Goodwill and Acquisition-Related Intangible Assets | Acquisition, Goodwill and Acquisition-Related Intangible Assets Acquisitions During the six months ended June 30, 2022, we completed two acquisitions of private companies for total consideration of $158.9 million including $4.0 million in common stock and the remainder in cash. The purchase prices included $62.3 million of intangible assets, $85.1 million of goodwill and $11.5 million of net assets acquired. We also incurred certain acquisition-related expenses of $4.7 million, which primarily consisted of retention bonuses to continuing employees as well as professional and consulting fees. The intangible assets are amortized on a straight-line basis over their estimated useful lives, as we believe this method most closely reflects the pattern in which the economic benefits of the assets will be consumed. The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition (in thousands, except years): Acquisition Date Fair Value Weighted Average Estimated Useful Life (in years) Developed technology $ 30,200 5.7 Customer relationships 28,700 7.0 Trade name 3,400 3.0 Total intangible assets acquired $ 62,300 Goodwill The changes in the carrying values of goodwill for the three and six months ended June 30, 2022 are as follows (in thousands): Amount Balance at December 31, 2021 $ 188,397 Additions related to the acquisition completed in January, 2022 28,518 Balance at March 31, 2022 $ 216,915 Additions related to the acquisition completed in June, 2022 56,530 Measurement-period adjustments to the acquisition completed in January, 2022 49 Balance at June 30, 2022 $ 273,494 Acquisition-Related Intangible Assets Acquisition-related intangible assets were as follows (in thousands, except years): Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful Life (in years) December 31, 2021 Additions June 30, 2022 December 31, 2021 Amortization June 30, 2022 December 31, 2021 June 30, 2022 Developed technology $ 124,730 $ 30,200 $ 154,930 $ (53,663) $ (11,732) $ (65,395) $ 71,067 $ 89,535 4.7 Customer relationships 25,920 28,700 54,620 (7,899) (2,347) (10,246) 18,021 44,374 6.1 Trade name 8,990 3,400 12,390 (4,693) (770) (5,463) 4,297 6,927 3.1 Others 5,720 — 5,720 (5,550) (170) (5,720) 170 — 0.0 Total $ 165,360 $ 62,300 $ 227,660 $ (71,805) $ (15,019) $ (86,824) $ 93,555 $ 140,836 5.1 Amortization expense related to acquisition-related intangible assets was $7.7 million, and $7.4 million for the three months ended June 30, 2022 and 2021, and $15.0 million and $14.8 million for the six months ended June 30, 2022 and 2021, respectively. As of June 30, 2022, future estimated amortization expense related to the acquisition-related intangible assets is as follows (in thousands): Future Amortization Expense Remainder of 2022 $ 18,630 2023 33,438 2024 26,759 2025 19,642 2026 17,260 Thereafter 25,107 Total $ 140,836 |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jun. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Purchase Commitments We outsource most of our manufacturing and supply chain management operations to third-party contract manufacturers, who procure components and assemble products on our behalf. A significant portion of our purchase orders to our contract manufacturers for finished products consists of non-cancellable purchase commitments. In addition, we purchase strategic component inventory from certain suppliers under non-cancellable purchase commitments, including integrated circuits, which are consigned to our contract manufacturers. As of June 30, 2022, we had non-cancellable purchase commitments of $4,472.2 million, out of which $2,937.6 million have confirmed receipt dates within 12 months, and $1,534.6 million have confirmed receipt dates greater than 12 months. These open purchase orders are considered enforceable and legally binding, and while we may have some limited ability to reschedule, and adjust our requirements based on our business needs prior to the delivery of goods or performance of services, this can only occur with the agreement of the related supplier. We also had deposits to our contract manufacturers to secure our purchase commitments in the amount of $100.8 million and $49.1 million as of June 30, 2022 and December 31, 2021, respectively, which were recorded within prepaid expenses and other current assets, as well as other assets in the condensed consolidated balance sheets. Guarantees We have entered into agreements with some of our direct customers and channel partners that contain indemnification provisions relating to potential situations where claims could be alleged that our products infringe the intellectual property rights of a third party. We have, at our option and expense, the ability to repair any infringement, replace product with a non-infringing equivalent-in-function product or refund our customers all or a portion of the value of the product. Other guarantees or indemnification agreements include guarantees of product and service performance and standby letters of credit for leased facilities and corporate credit cards. We have not recorded a liability related to these indemnification and guarantee provisions and our guarantee and indemnification arrangements have not had a significant impact on our consolidated financial statements to date. Legal Proceedings WSOU Investments, LLC On November 25, 2020, WSOU Investments LLC ("WSOU") filed a lawsuit against us in the Western District of Texas asserting that certain of our products infringe three WSOU patents. WSOU's allegations are directed to certain features of our wireless and switching products. WSOU seeks remedies including monetary damages, attorney's fees and costs. On February 4, 2021, we filed an answer denying WSOU's allegations. On November 5, 2021, the case was transferred to the Northern District of California. On March 30, 2022, WSOU dismissed one of the patents with prejudice, removing Arista wireless products from those accused of infringement. On July 1, 2022, the court stayed the case pending the resolution of an inter partes review of one of the patents-in-suit. We intend to vigorously defend against the claims brought against us by WSOU; however, we cannot be certain that any of WSOU's claims will be resolved in our favor, regardless of the merits of those claims. Any adverse litigation ruling could result in a significant damages award against us and injunctive relief. With respect to the legal proceedings described above, it is our belief that while a loss is not probable, it may be reasonably possible. Further, at this stage in the litigation, any possible loss or range of loss cannot be estimated; however, the outcome of litigation is inherently uncertain. Therefore, if this legal matter were resolved against us in a reporting period for a material amount, our consolidated financial statements for that reporting period could be materially adversely affected. Other matters In the ordinary course of business, we are a party to other claims and legal proceedings including matters relating to commercial, employee relations, business practices and intellectual property. We record a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. As of June 30, 2022, provisions recorded for contingent losses related to other claims and matters have not been significant. Based on currently-available information, management does not believe that any additional liabilities relating to other unresolved matters are probable or that the amount of any resulting loss is estimable, and believes these other matters are not likely, individually and in the aggregate, to have a material adverse effect on our financial position, results of operations or cash flows; however, litigation is subject to inherent uncertainties and our view of these matters may change in the future. Were an unfavorable outcome to occur, there exists the possibility of a material adverse |
Stockholders_ Equity and Stock-
Stockholders’ Equity and Stock-Based Compensation | 6 Months Ended |
Jun. 30, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Stockholders’ Equity and Stock-Based Compensation | Stockholders’ Equity and Stock-Based Compensation Stock Repurchase Program In April 2019, our board of directors authorized a $1.0 billion stock repurchase program (the "Repurchase Program"). This authorization allowed us to repurchase shares of our common stock over three years, and we completed our repurchases under the Repurchase Program during the fourth quarter of 2021. In the fourth quarter of 2021, our board of directors authorized an additional $1.0 billion stock repurchase program (the “New Repurchase Program”), which allows us to repurchase shares of our common stock to be funded from working capital. Repurchases may be made at management’s discretion from time to time on the open market, through privately negotiated transactions, transactions structured through investment banking institutions, block purchases, trading plans under Rule 10b5-1 of the Exchange Act, or a combination of the foregoing. The New Repurchase Program commenced in November 2021 and expires on the three-year anniversary thereof. The New Repurchase Program does not obligate us to acquire any of our common stock, and may be suspended or discontinued by us at any time without prior notice. As of June 30, 2022, the remaining authorized amount for stock repurchases under this program was approximately $307.2 million. A summary of the stock repurchase activity under the New Repurchase Program for the six months ended June 30, 2022 is as follows (in thousands, except per share amounts): Six Months Ended June 30, 2022 Aggregate purchase price $ 619,888 Shares repurchased 5,954 Average price paid per share $ 104.11 The aggregate purchase price of repurchased shares of our common stock is recorded as a reduction to retained earnings in our condensed consolidated statements of stockholders' equity. All shares repurchased have been retired. Equity Award Plan Activities 2014 Equity Incentive Plan In April 2014, our board of directors and stockholders approved the 2014 Equity Incentive Plan (the “2014 Plan”), effective on the first day that our common stock was publicly traded, and simultaneously terminated the 2004 and 2011 equity plans as to future grants; however, these plans will continue to govern the terms and conditions of the outstanding options previously granted thereunder. Awards granted under the 2014 Plan could be in the form of Incentive Stock Options (“ISOs”), Nonstatutory Stock Options (“NSOs”), Restricted Stock Units (“RSUs”), Restricted Stock Awards (“RSAs”) or Stock Appreciation Rights (“SARs”). The number of shares available for grant and issuance under the 2014 Plan increases automatically on January 1 of each year commencing with 2016 by the number of shares equal to 3% of the outstanding shares of our common stock on the immediately preceding December 31, but not to exceed 50,000,000 shares (the “2014 Plan Evergreen Increase”), unless our board of directors, in its discretion, determines to make a smaller increase. Effective January 1, 2022, our board of directors authorized an increase of 9,230,434 shares to the shares available for issuance under the 2014 Plan. As of June 30, 2022, there remained approximately 94.7 million shares available for issuance under the 2014 Plan. 2014 Employee Stock Purchase Plan In April 2014, our board of directors and stockholders approved the 2014 Employee Stock Purchase Plan (the “ESPP”). The ESPP became effective on the first day that our common stock was publicly traded. The number of shares reserved for issuance under the ESPP increases automatically on January 1 of each year by the number of shares equal to 1% of our shares outstanding immediately preceding December 31, but not to exceed 10,000,000 shares, unless our board of directors, in its discretion, determines to make a smaller increase. Effective January 1, 2022, our board of directors authorized an increase of 3,076,811 shares to the shares available for issuance under our 2014 Employee Stock Purchase Plan (the “ESPP”). During the six months ended June 30, 2022, we issued 240,394 shares at a weighted-average purchase price of $48.75 per share under the ESPP. As of June 30, 2022, there remained approximately 20.8 million shares available for issuance under the ESPP. Stock Option Activities The following table summarizes the option activity under our stock plans and related information (in thousands, except years and per share amounts): Number of Weighted- Weighted- Aggregate Balance—December 31, 2021 8,685 $ 12.45 2.8 $ 1,140,369 Options granted — — Options exercised (1,230) 9.17 Options canceled (164) 16.44 Balance—June 30, 2022 7,291 $ 12.91 2.4 $ 589,386 Vested and exercisable—June 30, 2022 6,145 $ 10.58 2.0 $ 511,007 Restricted Stock Unit (RSU) Activities A summary of the RSU activity is presented below (in thousands, except years and per share amounts): Number of Weighted- Weighted-Average Aggregate Intrinsic Value Unvested balance—December 31, 2021 7,821 $ 70.98 1.7 $ 1,124,229 RSUs granted 2,873 99.57 RSUs vested (1,374) 63.72 RSUs forfeited/canceled (272) 74.77 Unvested balance—June 30, 2022 9,048 $ 81.16 1.9 $ 848,123 Stock-Based Compensation Expense The following table summarizes the stock-based compensation expense related to our equity awards (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of revenue $ 2,312 $ 1,796 $ 3,621 $ 3,196 Research and development 28,449 23,139 56,025 45,121 Sales and marketing 12,827 11,368 25,936 21,453 General and administrative 6,636 8,641 14,921 12,727 Total stock-based compensation $ 50,224 $ 44,944 $ 100,503 $ 82,497 |
Net Income Per Share
Net Income Per Share | 6 Months Ended |
Jun. 30, 2022 | |
Earnings Per Share [Abstract] | |
Net Income Per Share | Net Income Per Share The following table sets forth the computation of our basic and diluted net income per share (in thousands, except per share amounts): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 (1) 2022 2021 (1) Numerator: Net income $ 299,099 $ 196,888 $ 571,358 $ 377,254 Denominator: Weighted-average shares used in computing net income per share, basic 306,754 305,844 307,399 305,536 Add weighted-average effect of dilutive securities: Stock options and RSUs 9,695 12,764 10,509 12,940 Employee stock purchase plan 132 232 132 232 Weighted-average shares used in computing net income per share, diluted 316,581 318,840 318,040 318,708 Net income per share: Basic $ 0.98 $ 0.64 $ 1.86 $ 1.23 Diluted $ 0.94 $ 0.62 $ 1.80 $ 1.18 (1) Prior periods have been adjusted to reflect the four-for-one stock split effected in the form of a stock dividend in November 2021. The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net income per share for the periods presented because their effect would have been anti-dilutive for the periods presented (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 (1) 2022 2021 (1) Stock options and RSUs 781 404 423 460 Employee stock purchase plan — 80 8 60 Total 781 484 431 520 (1) Prior periods have been adjusted to reflect the four-for-one stock split effected in the form of a stock dividend in November 2021. |
Income Taxes
Income Taxes | 6 Months Ended |
Jun. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes (in thousands, except percentages) Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Income before income taxes $ 362,320 $ 221,084 $ 671,787 $ 428,951 Provision for income taxes 63,221 24,196 100,429 51,697 Effective tax rate 17.4 % 10.9 % 14.9 % 12.1 % The increase in the effective tax rates in the three and six months ended June 30, 2022, as compared to the same periods in 2021, was primarily due to a decrease in the proportion of tax benefits attributable to stock-based compensation versus total pre-tax income. |
Geographical Information
Geographical Information | 6 Months Ended |
Jun. 30, 2022 | |
Segment Reporting [Abstract] | |
Geographical Information | Geographical Information We operate in one reportable segment. The following table represents revenue based on customers’ shipping addresses (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Americas $ 845,055 $ 514,149 $ 1,509,432 $ 1,016,021 Europe, Middle East and Africa 104,538 112,048 239,343 208,322 Asia-Pacific 102,298 81,122 180,182 150,538 Total revenue $ 1,051,891 $ 707,319 $ 1,928,957 $ 1,374,881 Long-lived assets, net, excluding intercompany receivables, investments in subsidiaries, privately-held equity investments and deferred tax assets, by location are summarized as follows (in thousands): June 30, 2022 December 31, 2021 United States $ 70,216 $ 62,163 International 21,607 16,471 Total $ 91,823 $ 78,634 |
Organization and Summary of S_2
Organization and Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Jun. 30, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Principles of Consolidation | Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Arista Networks, Inc. and its wholly-owned subsidiaries and have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and the requirements of the U.S. Securities and Exchange Commission (the “SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP can be condensed or omitted. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments, which include only normal recurring adjustments, necessary for the fair presentation of our financial information. The results for the three and six months ended June 30, 2022, are not necessarily indicative of the results expected for the full fiscal year. The condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited consolidated financial statements at that date but does not include all of the information and notes required by GAAP for complete financial statements. All significant inter-company accounts and transactions have been eliminated. |
Use of Estimates | Use of Estimates The preparation of the accompanying consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Those estimates and assumptions include, but are not limited to, valuation of inventory and contract manufacturer/supplier liabilities, accounting for income taxes, including the recognition of deferred tax assets and liabilities, valuation allowance on deferred tax assets and reserves for uncertain tax positions, revenue recognition and deferred revenue, allowance for doubtful accounts, sales rebates and return reserves, valuation of goodwill and acquisition-related intangible assets, estimate of useful lives of long-lived assets including intangible assets, and the recognition and measurement of contingent liabilities. We evaluate our estimates and assumptions based on historical experience and other factors and adjust these estimates and assumptions when facts and circumstances dictate. Actual results could differ materially from these estimates. |
Risks And Uncertainties | Risks and Uncertainties Global economic and business activities continue to face widespread macroeconomic uncertainties, including supply chain and labor shortages, inflation and monetary policy shifts, recession risks, the ongoing global coronavirus ("COVID-19") pandemic and potential disruptions from the Russia-Ukraine conflict. Our contract manufacturers and suppliers have experienced workforce disruptions, delays in component sourcing, production and export of their products as well as component shortages and increased component costs, which have disrupted our supply chain and have impacted and will likely continue to impact our ability to supply products to our customers on a timely basis. While we continue to experience strong overall demand from customers, we believe ongoing supply disruptions combined with other supply chain related constraints could impact our ability to fulfill this increased demand and as a result could negatively impact our business in future periods. In addition, inflation pressure in our supply chain and scarcity of some materials needed to build our products have increased our cost of revenue and have impacted, and may continue to negatively impact our gross margin. The extent of the impact on our operational and financial performance, including our ability to execute our business strategies and initiatives in the expected time frame, and the impact of any initiatives and programs we may undertake to address financial and operational challenges, will depend on future developments, the impact to our customers, partners, employees, contract manufacturers and supply chain, as well as restrictions on travel and transport, all of which continue to evolve and are unpredictable. Management continues to actively monitor the impact of these macroeconomic factors |
Recently Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. ASU 2021-08 requires companies to recognize and measure contract assets and contract liabilities relating to contracts with customers that are acquired in a business combination in accordance with ASC 606. Under previous GAAP, an acquirer generally recognizes assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. ASU No. 2021-08 results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC Topic 606. The ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company adopted this ASU as of January 1, 2022 on a prospective basis and the adoption impact was immaterial to the condensed consolidated financial statements. The standard will not impact acquired contract assets or liabilities from business combinations occurring prior to the adoption date. |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jun. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Summary of Fair Value of Financial Assets by Level | The following tables summarize the fair value of these financial assets by significant investment category and their levels within the fair value hierarchy (in thousands): As of June 30, 2022 As of December 31, 2021 Level I Level II Level III Total Level I Level II Level III Total Financial Assets: Cash Equivalents: Money market funds $ 274,754 $ — $ — $ 274,754 $ 221,382 $ — $ — $ 221,382 Commercial paper — 3,642 — 3,642 — — — — 274,754 3,642 — 278,396 221,382 — — 221,382 Marketable Securities: Commercial paper — 18,462 — 18,462 — 141,274 — 141,274 Certificate of deposits (1) — 13,030 — 13,030 — 44,931 — 44,931 U.S. government notes 1,082,084 — — 1,082,084 1,057,810 — — 1,057,810 Corporate bonds — 1,066,585 — 1,066,585 — 1,252,226 — 1,252,226 Agency securities — 211,768 — 211,768 — 291,261 — 291,261 Marketable equity securities (2) 16,727 — — 16,727 — — — — 1,098,811 1,309,845 — 2,408,656 1,057,810 1,729,692 — 2,787,502 Other Assets: Money market funds - restricted 4,258 — — 4,258 4,237 — — 4,237 Total Financial Assets $ 1,377,823 $ 1,313,487 $ — $ 2,691,310 $ 1,283,429 $ 1,729,692 $ — $ 3,013,121 ______________________________________ (1) As of June 30, 2022 and December 31, 2021, all of our certificates of deposits were domestic deposits. (2) The $16.7 million represents the fair value of marketable equity securities as of June 30, 2022. This amount includes $8.3 million that was reclassified from Investments on our condensed consolidated balance sheet following the commencement of public market trading of the issuer in January 2022. This publicly-traded equity investment generated an unrealized gain of $8.4 million for the six months ended June 30, 2022, and an unrealized loss of $5.1 million for the three months ended June 30, 2022. The unrealized gains and losses are included in Other income (expense), net on the Condensed Consolidated Statements of Operations. Refer to Note 3. Financial Statements Details. As of June 30, 2022 As of December 31, 2021 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Amortized Cost Unrealized Gains Unrealized Losses Fair Value Commercial paper $ 18,462 $ — $ — $ 18,462 $ 141,274 $ — $ — $ 141,274 U.S. government 1,098,360 — (16,276) 1,082,084 1,060,716 3 (2,909) 1,057,810 Corporate bonds 1,083,803 6 (17,224) 1,066,585 1,255,149 105 (3,028) 1,252,226 Agency securities 214,687 1 (2,920) 211,768 291,558 36 (333) 291,261 Total $ 2,415,312 $ 7 $ (36,420) $ 2,378,899 $ 2,748,697 $ 144 $ (6,270) $ 2,742,571 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value | The following table is an analysis of our marketable debt securities in unrealized loss positions (in thousands): As of June 30, 2022 Unrealized Losses within 12 months Unrealized Losses 12 months or greater Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. government notes $ 1,082,084 $ (16,276) $ — $ — $ 1,082,084 $ (16,276) Corporate bonds 995,771 (16,075) 65,373 (1,149) 1,061,144 (17,224) Agency securities 206,768 (2,920) — — 206,768 (2,920) Total $ 2,284,623 $ (35,271) $ 65,373 $ (1,149) $ 2,349,996 $ (36,420) |
Fair Value of Available-For-Sale Investments By Contractual Maturity | The fair values of marketable debt securities, by remaining contractual maturities, are as follows (in thousands): As of June 30, 2022 Fair Value Due in 1 year or less $ 1,700,701 Due in 1 to 2 years 678,198 Total debt securities $ 2,378,899 |
Equity Securities without Readily Determinable Fair Value | The following table summarizes the activity related to our non-marketable equity securities as of June 30, 2022 and December 31, 2021 (in thousands): June 30, 2022 December 31, 2021 Cost of investments (1) $ 23,263 $ 14,933 Cumulative impairment — — Cumulative upward adjustment (1) 15,000 5,314 Carrying amount of investments $ 38,263 $ 20,247 |
Financial Statements Details (T
Financial Statements Details (Tables) | 6 Months Ended |
Jun. 30, 2022 | |
Balance Sheet Components [Abstract] | |
Schedule of Cash, Cash Equivalents and Restricted Cash | The reconciliation of cash, cash equivalents and restricted cash reported on the unaudited condensed consolidated balance sheets to the total of the same such amounts in the unaudited condensed consolidated statements of cash flows is as follows (in thousands): June 30, 2022 December 31, 2021 Cash and cash equivalents $ 493,246 $ 620,813 Restricted cash included in other assets 4,258 4,237 Total cash, cash equivalents and restricted cash $ 497,504 $ 625,050 |
Schedule of Accounts Receivable, Net | Accounts receivable, net consists of the following (in thousands): June 30, 2022 December 31, 2021 Accounts receivable $ 598,380 $ 521,597 Allowance for doubtful accounts (207) (132) Product sales rebate and returns reserve (12,387) (4,956) Accounts receivable, net $ 585,786 $ 516,509 |
Schedule of Inventories | Inventories consist of the following (in thousands): June 30, 2022 December 31, 2021 Raw materials $ 462,396 $ 316,737 Finished goods 390,414 333,380 Total inventories $ 852,810 $ 650,117 |
Schedule of Prepaid Expenses and Other Current Assets | Prepaid expenses and other current assets consist of the following (in thousands): June 30, 2022 December 31, 2021 Inventory deposits $ 98,099 $ 46,311 Prepaid income taxes 10,189 8,977 Other current assets 256,102 163,916 Other prepaid expenses and deposits 24,307 18,531 Total prepaid expenses and other current assets $ 388,697 $ 237,735 |
Schedule of Property and Equipment, Net | Property and equipment, net consists of the following (in thousands): June 30, 2022 December 31, 2021 Land $ 40,485 $ 40,145 Equipment and machinery 111,646 90,915 Computer hardware and software 47,376 44,083 Leasehold improvements 30,208 30,502 Furniture and fixtures 3,612 3,634 Construction-in-process 2,207 2,378 Property and equipment, gross 235,534 211,657 Less: accumulated depreciation (143,711) (133,023) Property and equipment, net $ 91,823 $ 78,634 |
Schedule of Accrued Liabilities | Accrued liabilities consist of the following (in thousands): June 30, 2022 December 31, 2021 Accrued payroll related costs $ 78,066 $ 99,571 Accrued manufacturing costs 79,949 80,213 Accrued product development costs 24,311 22,188 Accrued warranty costs 13,288 10,414 Other 14,720 14,257 Total accrued liabilities $ 210,334 $ 226,643 |
Schedule of Warranty Accrual | The following table summarizes the activity related to our accrued liability for estimated future warranty costs (in thousands): Six Months Ended June 30, 2022 2021 Warranty accrual, beginning of period $ 10,414 $ 9,314 Liabilities accrued for warranties issued during the period 8,441 5,603 Warranty costs incurred during the period (5,567) (5,922) Warranty accrual, end of period $ 13,288 $ 8,995 |
Schedule of Contract Assets, Contract Liabilities and Deferred Revenue | The following table summarizes the beginning and ending balances of our contract assets included in "Prepaid and other current assets" on the condensed consolidated balance sheets (in thousands): Six Months Ended June 30, 2022 Contract assets, beginning balance $ 24,388 Contract assets, ending balance 29,237 Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Contract liabilities, beginning balance $ 98,422 $ 80,465 $ 93,382 $ 85,957 Less: Revenue recognized from beginning balance (8,589) (8,482) (19,076) (18,482) Less: Beginning balance reclassified to deferred revenue (4,338) (3,856) (3,606) (12,710) Add: Contract liabilities recognized 16,105 15,227 30,900 28,589 Contract liabilities, ending balance $ 101,600 $ 83,354 $ 101,600 $ 83,354 Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Deferred revenue, beginning balance $ 1,123,746 $ 720,031 $ 929,312 $ 650,827 Less: Revenue recognized from beginning balance (309,594) (145,556) (322,954) (222,865) Add: Deferral of revenue in current period, excluding amounts recognized during the period 219,338 171,615 427,132 318,128 Deferred revenue, ending balance $ 1,033,490 $ 746,090 $ 1,033,490 $ 746,090 |
Schedule of Other Income (Expense), Net | Other income (expense), net consists of the following (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Interest income $ 4,427 $ 1,872 $ 6,855 $ 3,917 Unrealized gain (loss) on equity investments (5,084) — 23,413 — Other income (expense), net 124 (153) 679 (623) Total $ (533) $ 1,719 $ 30,947 $ 3,294 |
Acquisition, Goodwill and Acq_2
Acquisition, Goodwill and Acquisition-Related Intangible Assets (Tables) | 6 Months Ended |
Jun. 30, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Acquisition-Related Intangible Assets | The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition (in thousands, except years): Acquisition Date Fair Value Weighted Average Estimated Useful Life (in years) Developed technology $ 30,200 5.7 Customer relationships 28,700 7.0 Trade name 3,400 3.0 Total intangible assets acquired $ 62,300 |
Schedule of Goodwill | The changes in the carrying values of goodwill for the three and six months ended June 30, 2022 are as follows (in thousands): Amount Balance at December 31, 2021 $ 188,397 Additions related to the acquisition completed in January, 2022 28,518 Balance at March 31, 2022 $ 216,915 Additions related to the acquisition completed in June, 2022 56,530 Measurement-period adjustments to the acquisition completed in January, 2022 49 Balance at June 30, 2022 $ 273,494 |
Schedule of Finite-Lived Intangible Assets | Acquisition-related intangible assets were as follows (in thousands, except years): Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful Life (in years) December 31, 2021 Additions June 30, 2022 December 31, 2021 Amortization June 30, 2022 December 31, 2021 June 30, 2022 Developed technology $ 124,730 $ 30,200 $ 154,930 $ (53,663) $ (11,732) $ (65,395) $ 71,067 $ 89,535 4.7 Customer relationships 25,920 28,700 54,620 (7,899) (2,347) (10,246) 18,021 44,374 6.1 Trade name 8,990 3,400 12,390 (4,693) (770) (5,463) 4,297 6,927 3.1 Others 5,720 — 5,720 (5,550) (170) (5,720) 170 — 0.0 Total $ 165,360 $ 62,300 $ 227,660 $ (71,805) $ (15,019) $ (86,824) $ 93,555 $ 140,836 5.1 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | As of June 30, 2022, future estimated amortization expense related to the acquisition-related intangible assets is as follows (in thousands): Future Amortization Expense Remainder of 2022 $ 18,630 2023 33,438 2024 26,759 2025 19,642 2026 17,260 Thereafter 25,107 Total $ 140,836 |
Stockholders_ Equity and Stoc_2
Stockholders’ Equity and Stock-Based Compensation (Tables) | 6 Months Ended |
Jun. 30, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Shares Repurchased | A summary of the stock repurchase activity under the New Repurchase Program for the six months ended June 30, 2022 is as follows (in thousands, except per share amounts): Six Months Ended June 30, 2022 Aggregate purchase price $ 619,888 Shares repurchased 5,954 Average price paid per share $ 104.11 |
Schedule of Option Activity | The following table summarizes the option activity under our stock plans and related information (in thousands, except years and per share amounts): Number of Weighted- Weighted- Aggregate Balance—December 31, 2021 8,685 $ 12.45 2.8 $ 1,140,369 Options granted — — Options exercised (1,230) 9.17 Options canceled (164) 16.44 Balance—June 30, 2022 7,291 $ 12.91 2.4 $ 589,386 Vested and exercisable—June 30, 2022 6,145 $ 10.58 2.0 $ 511,007 |
Schedule of Restricted Stock Units Activity | A summary of the RSU activity is presented below (in thousands, except years and per share amounts): Number of Weighted- Weighted-Average Aggregate Intrinsic Value Unvested balance—December 31, 2021 7,821 $ 70.98 1.7 $ 1,124,229 RSUs granted 2,873 99.57 RSUs vested (1,374) 63.72 RSUs forfeited/canceled (272) 74.77 Unvested balance—June 30, 2022 9,048 $ 81.16 1.9 $ 848,123 |
Schedule of Stock-Based Compensation Expense | The following table summarizes the stock-based compensation expense related to our equity awards (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of revenue $ 2,312 $ 1,796 $ 3,621 $ 3,196 Research and development 28,449 23,139 56,025 45,121 Sales and marketing 12,827 11,368 25,936 21,453 General and administrative 6,636 8,641 14,921 12,727 Total stock-based compensation $ 50,224 $ 44,944 $ 100,503 $ 82,497 |
Net Income Per Share (Tables)
Net Income Per Share (Tables) | 6 Months Ended |
Jun. 30, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Basic and Diluted Net Income Per Share Available to Common Stock | The following table sets forth the computation of our basic and diluted net income per share (in thousands, except per share amounts): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 (1) 2022 2021 (1) Numerator: Net income $ 299,099 $ 196,888 $ 571,358 $ 377,254 Denominator: Weighted-average shares used in computing net income per share, basic 306,754 305,844 307,399 305,536 Add weighted-average effect of dilutive securities: Stock options and RSUs 9,695 12,764 10,509 12,940 Employee stock purchase plan 132 232 132 232 Weighted-average shares used in computing net income per share, diluted 316,581 318,840 318,040 318,708 Net income per share: Basic $ 0.98 $ 0.64 $ 1.86 $ 1.23 Diluted $ 0.94 $ 0.62 $ 1.80 $ 1.18 (1) Prior periods have been adjusted to reflect the four-for-one stock split effected in the form of a stock dividend in November 2021. |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net income per share for the periods presented because their effect would have been anti-dilutive for the periods presented (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 (1) 2022 2021 (1) Stock options and RSUs 781 404 423 460 Employee stock purchase plan — 80 8 60 Total 781 484 431 520 (1) Prior periods have been adjusted to reflect the four-for-one stock split effected in the form of a stock dividend in November 2021. |
Income Taxes (Tables)
Income Taxes (Tables) | 6 Months Ended |
Jun. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income Tax Expense (Benefit) | Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Income before income taxes $ 362,320 $ 221,084 $ 671,787 $ 428,951 Provision for income taxes 63,221 24,196 100,429 51,697 Effective tax rate 17.4 % 10.9 % 14.9 % 12.1 % |
Geographical Information (Table
Geographical Information (Tables) | 6 Months Ended |
Jun. 30, 2022 | |
Segment Reporting [Abstract] | |
Schedule of Revenue and Long Lived Assets, by Location | The following table represents revenue based on customers’ shipping addresses (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Americas $ 845,055 $ 514,149 $ 1,509,432 $ 1,016,021 Europe, Middle East and Africa 104,538 112,048 239,343 208,322 Asia-Pacific 102,298 81,122 180,182 150,538 Total revenue $ 1,051,891 $ 707,319 $ 1,928,957 $ 1,374,881 Long-lived assets, net, excluding intercompany receivables, investments in subsidiaries, privately-held equity investments and deferred tax assets, by location are summarized as follows (in thousands): June 30, 2022 December 31, 2021 United States $ 70,216 $ 62,163 International 21,607 16,471 Total $ 91,823 $ 78,634 |
Fair Value Measurements - Sched
Fair Value Measurements - Schedule of Fair Value of Financial Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | Dec. 31, 2021 | |
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | $ 278,396 | $ 278,396 | $ 221,382 | ||
Marketable Securities, Fair Value | 2,378,899 | 2,378,899 | 2,742,571 | ||
Total Financial Assets, Fair Value | 2,691,310 | 2,691,310 | 3,013,121 | ||
Unrealized gain (loss) on equity investments | (5,084) | $ 0 | 23,413 | $ 0 | |
Fair Value to Amortized Cost | |||||
Amortized Cost | 2,415,312 | 2,415,312 | 2,748,697 | ||
Unrealized Gains | 7 | 7 | 144 | ||
Unrealized Losses | (36,420) | (36,420) | (6,270) | ||
Fair Value | 2,378,899 | 2,378,899 | 2,742,571 | ||
Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 274,754 | 274,754 | 221,382 | ||
Total Financial Assets, Fair Value | 1,377,823 | 1,377,823 | 1,283,429 | ||
Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 3,642 | 3,642 | 0 | ||
Total Financial Assets, Fair Value | 1,313,487 | 1,313,487 | 1,729,692 | ||
Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 0 | 0 | 0 | ||
Total Financial Assets, Fair Value | 0 | 0 | 0 | ||
Commercial paper | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 18,462 | 18,462 | 141,274 | ||
Fair Value to Amortized Cost | |||||
Amortized Cost | 18,462 | 18,462 | 141,274 | ||
Unrealized Gains | 0 | 0 | 0 | ||
Unrealized Losses | 0 | 0 | 0 | ||
Fair Value | 18,462 | 18,462 | 141,274 | ||
Commercial paper | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Commercial paper | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 18,462 | 18,462 | 141,274 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 18,462 | 18,462 | 141,274 | ||
Commercial paper | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Certificate of deposits | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 13,030 | 13,030 | 44,931 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 13,030 | 13,030 | 44,931 | ||
Certificate of deposits | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Certificate of deposits | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 13,030 | 13,030 | 44,931 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 13,030 | 13,030 | 44,931 | ||
Certificate of deposits | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
U.S. government notes | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 1,082,084 | 1,082,084 | 1,057,810 | ||
Fair Value to Amortized Cost | |||||
Amortized Cost | 1,098,360 | 1,098,360 | 1,060,716 | ||
Unrealized Gains | 0 | 0 | 3 | ||
Unrealized Losses | (16,276) | (16,276) | (2,909) | ||
Fair Value | 1,082,084 | 1,082,084 | 1,057,810 | ||
U.S. government notes | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 1,082,084 | 1,082,084 | 1,057,810 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 1,082,084 | 1,082,084 | 1,057,810 | ||
U.S. government notes | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
U.S. government notes | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Corporate bonds | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 1,066,585 | 1,066,585 | 1,252,226 | ||
Fair Value to Amortized Cost | |||||
Amortized Cost | 1,083,803 | 1,083,803 | 1,255,149 | ||
Unrealized Gains | 6 | 6 | 105 | ||
Unrealized Losses | (17,224) | (17,224) | (3,028) | ||
Fair Value | 1,066,585 | 1,066,585 | 1,252,226 | ||
Corporate bonds | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Corporate bonds | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 1,066,585 | 1,066,585 | 1,252,226 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 1,066,585 | 1,066,585 | 1,252,226 | ||
Corporate bonds | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Agency securities | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 211,768 | 211,768 | 291,261 | ||
Fair Value to Amortized Cost | |||||
Amortized Cost | 214,687 | 214,687 | 291,558 | ||
Unrealized Gains | 1 | 1 | 36 | ||
Unrealized Losses | (2,920) | (2,920) | (333) | ||
Fair Value | 211,768 | 211,768 | 291,261 | ||
Agency securities | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Agency securities | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 211,768 | 211,768 | 291,261 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 211,768 | 211,768 | 291,261 | ||
Agency securities | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Marketable equity securities | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 16,727 | 16,727 | 0 | ||
Fair value of securities reclassified | 8,300 | ||||
Unrealized gain (loss) on equity investments | (5,100) | 8,400 | |||
Fair Value to Amortized Cost | |||||
Fair Value | 16,727 | 16,727 | 0 | ||
Marketable equity securities | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 16,727 | 16,727 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 16,727 | 16,727 | 0 | ||
Marketable equity securities | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Marketable equity securities | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Marketable Securities | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 2,408,656 | 2,408,656 | 2,787,502 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 2,408,656 | 2,408,656 | 2,787,502 | ||
Marketable Securities | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 1,098,811 | 1,098,811 | 1,057,810 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 1,098,811 | 1,098,811 | 1,057,810 | ||
Marketable Securities | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 1,309,845 | 1,309,845 | 1,729,692 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 1,309,845 | 1,309,845 | 1,729,692 | ||
Marketable Securities | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Marketable Securities, Fair Value | 0 | 0 | 0 | ||
Fair Value to Amortized Cost | |||||
Fair Value | 0 | 0 | 0 | ||
Money market funds - restricted | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Other Assets, Fair Value | 4,258 | 4,258 | 4,237 | ||
Money market funds - restricted | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Other Assets, Fair Value | 4,258 | 4,258 | 4,237 | ||
Money market funds - restricted | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Other Assets, Fair Value | 0 | 0 | 0 | ||
Money market funds - restricted | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Other Assets, Fair Value | 0 | 0 | 0 | ||
Money market funds | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 274,754 | 274,754 | 221,382 | ||
Money market funds | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 274,754 | 274,754 | 221,382 | ||
Money market funds | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 0 | 0 | 0 | ||
Money market funds | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 0 | 0 | 0 | ||
Commercial paper | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 3,642 | 3,642 | 0 | ||
Commercial paper | Level I | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 0 | 0 | 0 | ||
Commercial paper | Level II | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | 3,642 | 3,642 | 0 | ||
Commercial paper | Level III | |||||
Assets, Fair Value Disclosure [Abstract] | |||||
Cash Equivalents, Fair Value | $ 0 | $ 0 | $ 0 |
Fair Value Measurements - Unrea
Fair Value Measurements - Unrealized Loss Position (Details) $ in Thousands | Jun. 30, 2022 USD ($) |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Unrealized Losses within 12 months, Fair Value | $ 2,284,623 |
Unrealized Losses within 12 months, Unrealized Losses | (35,271) |
Unrealized Losses 12 months or greater, Fair Value | 65,373 |
Unrealized Losses 12 months or greater, Unrealized Losses | (1,149) |
Total, Fair Value | 2,349,996 |
Total, Unrealized Losses | (36,420) |
U.S. government notes | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Unrealized Losses within 12 months, Fair Value | 1,082,084 |
Unrealized Losses within 12 months, Unrealized Losses | (16,276) |
Unrealized Losses 12 months or greater, Fair Value | 0 |
Unrealized Losses 12 months or greater, Unrealized Losses | 0 |
Total, Fair Value | 1,082,084 |
Total, Unrealized Losses | (16,276) |
Corporate bonds | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Unrealized Losses within 12 months, Fair Value | 995,771 |
Unrealized Losses within 12 months, Unrealized Losses | (16,075) |
Unrealized Losses 12 months or greater, Fair Value | 65,373 |
Unrealized Losses 12 months or greater, Unrealized Losses | (1,149) |
Total, Fair Value | 1,061,144 |
Total, Unrealized Losses | (17,224) |
Agency securities | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Unrealized Losses within 12 months, Fair Value | 206,768 |
Unrealized Losses within 12 months, Unrealized Losses | (2,920) |
Unrealized Losses 12 months or greater, Fair Value | 0 |
Unrealized Losses 12 months or greater, Unrealized Losses | 0 |
Total, Fair Value | 206,768 |
Total, Unrealized Losses | $ (2,920) |
Fair Value Measurements - Narra
Fair Value Measurements - Narrative (Details) $ in Millions | 6 Months Ended |
Jun. 30, 2022 USD ($) | |
Fair Value Disclosures [Abstract] | |
Invested marketable securities, maximum maturity period | 2 years |
Marketable securities, maximum maturity period | 24 months |
Marketable securities, weighted average remaining duration | 9 months 18 days |
Unrealized gain on non-marketable equity securities | $ 15 |
Fair Value Measurements - Inves
Fair Value Measurements - Investment by Maturity Dates (Details) - USD ($) $ in Thousands | Jun. 30, 2022 | Dec. 31, 2021 |
Fair Value Disclosures [Abstract] | ||
Due in 1 year or less | $ 1,700,701 | |
Due in 1 to 2 years | 678,198 | |
Total debt securities | $ 2,378,899 | $ 2,742,571 |
Fair Value Measurements - Nonma
Fair Value Measurements - Nonmarketable Equity Securities (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2022 | Dec. 31, 2021 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Cost of investments | $ 23,263 | $ 14,933 |
Cumulative impairment | 0 | 0 |
Cumulative upward adjustment | 15,000 | 5,314 |
Carrying amount of investments | 38,263 | $ 20,247 |
Cost of investments, reclassified | 3,000 | |
Cumulative upward adjustment, reclassified | 5,300 | |
Marketable equity securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair value of securities reclassified | $ 8,300 |
Financial Statements Details -
Financial Statements Details - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands | Jun. 30, 2022 | Dec. 31, 2021 | Jun. 30, 2021 | Dec. 31, 2020 |
Balance Sheet Components [Abstract] | ||||
Cash and cash equivalents | $ 493,246 | $ 620,813 | ||
Restricted cash included in other assets | 4,258 | 4,237 | ||
Total cash, cash equivalents and restricted cash | $ 497,504 | $ 625,050 | $ 897,924 | $ 897,454 |
Financial Statements Details _2
Financial Statements Details - Accounts Receivable, net (Details) - USD ($) $ in Thousands | Jun. 30, 2022 | Dec. 31, 2021 |
Balance Sheet Components [Abstract] | ||
Accounts receivable | $ 598,380 | $ 521,597 |
Allowance for doubtful accounts | (207) | (132) |
Product sales rebate and returns reserve | (12,387) | (4,956) |
Accounts receivable, net | $ 585,786 | $ 516,509 |
Financial Statements Details _3
Financial Statements Details - Inventories (Details) - USD ($) $ in Thousands | Jun. 30, 2022 | Dec. 31, 2021 |
Balance Sheet Components [Abstract] | ||
Raw materials | $ 462,396 | $ 316,737 |
Finished goods | 390,414 | 333,380 |
Total inventories | $ 852,810 | $ 650,117 |
Financial Statements Details _4
Financial Statements Details - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands | Jun. 30, 2022 | Dec. 31, 2021 |
Balance Sheet Components [Abstract] | ||
Inventory deposits | $ 98,099 | $ 46,311 |
Prepaid income taxes | 10,189 | 8,977 |
Other current assets | 256,102 | 163,916 |
Other prepaid expenses and deposits | 24,307 | 18,531 |
Total prepaid expenses and other current assets | $ 388,697 | $ 237,735 |
Financial Statements Details _5
Financial Statements Details - Property and Equipment, net (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | Dec. 31, 2021 | |
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | $ 235,534 | $ 235,534 | $ 211,657 | ||
Less: accumulated depreciation | (143,711) | (143,711) | (133,023) | ||
Property and equipment, net | 91,823 | 91,823 | 78,634 | ||
Depreciation | 6,200 | $ 4,800 | 11,800 | $ 9,700 | |
Land | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 40,485 | 40,485 | 40,145 | ||
Equipment and machinery | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 111,646 | 111,646 | 90,915 | ||
Computer hardware and software | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 47,376 | 47,376 | 44,083 | ||
Leasehold improvements | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 30,208 | 30,208 | 30,502 | ||
Furniture and fixtures | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | 3,612 | 3,612 | 3,634 | ||
Construction-in-process | |||||
Property, Plant and Equipment [Line Items] | |||||
Property and equipment, gross | $ 2,207 | $ 2,207 | $ 2,378 |
Financial Statements Details _6
Financial Statements Details - Accrued Liabilities (Details) - USD ($) $ in Thousands | Jun. 30, 2022 | Dec. 31, 2021 | Jun. 30, 2021 | Dec. 31, 2020 |
Balance Sheet Components [Abstract] | ||||
Accrued payroll related costs | $ 78,066 | $ 99,571 | ||
Accrued manufacturing costs | 79,949 | 80,213 | ||
Accrued product development costs | 24,311 | 22,188 | ||
Accrued warranty costs | 13,288 | 10,414 | $ 8,995 | $ 9,314 |
Other | 14,720 | 14,257 | ||
Total accrued liabilities | $ 210,334 | $ 226,643 |
Financial Statements Details _7
Financial Statements Details - Warranty Accrual (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2022 | Jun. 30, 2021 | |
Warranty [Roll Forward] | ||
Warranty accrual, beginning of period | $ 10,414 | $ 9,314 |
Liabilities accrued for warranties issued during the period | 8,441 | 5,603 |
Warranty costs incurred during the period | (5,567) | (5,922) |
Warranty accrual, end of period | $ 13,288 | $ 8,995 |
Financial Statements Details _8
Financial Statements Details - Contract Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | |
Change in Contract with Customer, Asset [Roll Forward] | ||||
Contract assets, beginning balance | $ 24,388 | |||
Contract assets, ending balance | $ 29,237 | 29,237 | ||
Change in Contract with Customer, Liability [Roll Forward] | ||||
Contract liabilities, beginning balance | 98,422 | $ 80,465 | 93,382 | $ 85,957 |
Less: Revenue recognized from beginning balance | (8,589) | (8,482) | (19,076) | (18,482) |
Less: Beginning balance reclassified to deferred revenue | (4,338) | (3,856) | (3,606) | (12,710) |
Add: Contract liabilities recognized | 16,105 | 15,227 | 30,900 | 28,589 |
Contract liabilities, ending balance | 101,600 | $ 83,354 | 101,600 | $ 83,354 |
Other Current Liabilities | ||||
Change in Contract with Customer, Liability [Roll Forward] | ||||
Contract liabilities, beginning balance | 38,700 | |||
Contract liabilities, ending balance | $ 41,400 | $ 41,400 |
Financial Statements Details _9
Financial Statements Details - Deferred Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | |
Change in Contract with Customer, Liability [Roll Forward] | ||||
Deferred revenue, beginning balance | $ 1,123,746 | $ 720,031 | $ 929,312 | $ 650,827 |
Less: Revenue recognized from beginning balance | (309,594) | (145,556) | (322,954) | (222,865) |
Add: Deferral of revenue in current period, excluding amounts recognized during the period | 219,338 | 171,615 | 427,132 | 318,128 |
Deferred revenue, ending balance | $ 1,033,490 | $ 746,090 | $ 1,033,490 | $ 746,090 |
Financial Statements Details_10
Financial Statements Details - Revenue from Total Remaining Performance Obligations (Details) $ in Millions | Jun. 30, 2022 USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | $ 1,313.3 |
Product | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | 762.7 |
Unbilled Revenues | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | $ 178.1 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, performance obligation, percentage | 83% |
Revenue, performance obligation, period | 2 years |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01 | Product | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, performance obligation, period | 2 years |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, performance obligation, percentage | 17% |
Revenue, performance obligation, period | 3 years |
Financial Statements Details_11
Financial Statements Details - Other Income (Expense), net (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | |
Balance Sheet Components [Abstract] | ||||
Interest income | $ 4,427 | $ 1,872 | $ 6,855 | $ 3,917 |
Unrealized gain (loss) on equity investments | (5,084) | 0 | 23,413 | 0 |
Other income (expense), net | 124 | (153) | 679 | (623) |
Total other income (expense), net | $ (533) | $ 1,719 | $ 30,947 | $ 3,294 |
Acquisition, Goodwill and Acq_3
Acquisition, Goodwill and Acquisition-Related Intangible Assets - Narrative (Details) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2022 USD ($) | Mar. 31, 2022 USD ($) | Jun. 30, 2021 USD ($) | Jun. 30, 2022 USD ($) acquisition | Jun. 30, 2021 USD ($) | |
Business Acquisition [Line Items] | |||||
Number of completed acquisitions | acquisition | 2 | ||||
Goodwill acquired | $ 56,530 | $ 28,518 | |||
Amortization of intangible assets | $ 15,019 | ||||
Privately-held Technology Company | |||||
Business Acquisition [Line Items] | |||||
Total fair value of consideration transferred | 158,900 | ||||
Common stock consideration | 4,000 | ||||
Intangible assets | 62,300 | 62,300 | |||
Goodwill acquired | 85,100 | ||||
Net assets acquired | 11,500 | 11,500 | |||
Acquisition related costs | 4,700 | ||||
Amortization of intangible assets | $ 7,700 | $ 7,400 | $ 15,000 | $ 14,800 |
Acquisition, Goodwill and Acq_4
Acquisition, Goodwill and Acquisition-Related Intangible Assets - Identifiable Intangible Assets Acquired (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2022 USD ($) | |
Finite-Lived Intangible Assets [Line Items] | |
Weighted Average Estimated Useful Life (in years) | 5 years 1 month 6 days |
Developed technology | |
Finite-Lived Intangible Assets [Line Items] | |
Weighted Average Estimated Useful Life (in years) | 4 years 8 months 12 days |
Customer relationships | |
Finite-Lived Intangible Assets [Line Items] | |
Weighted Average Estimated Useful Life (in years) | 6 years 1 month 6 days |
Trade name | |
Finite-Lived Intangible Assets [Line Items] | |
Weighted Average Estimated Useful Life (in years) | 3 years 1 month 6 days |
Privately-held Technology Company | |
Finite-Lived Intangible Assets [Line Items] | |
Acquisition-related intangible assets, net | $ 62,300 |
Privately-held Technology Company | Developed technology | |
Finite-Lived Intangible Assets [Line Items] | |
Acquisition-related intangible assets, net | $ 30,200 |
Weighted Average Estimated Useful Life (in years) | 5 years 8 months 12 days |
Privately-held Technology Company | Customer relationships | |
Finite-Lived Intangible Assets [Line Items] | |
Acquisition-related intangible assets, net | $ 28,700 |
Weighted Average Estimated Useful Life (in years) | 7 years |
Privately-held Technology Company | Trade name | |
Finite-Lived Intangible Assets [Line Items] | |
Acquisition-related intangible assets, net | $ 3,400 |
Weighted Average Estimated Useful Life (in years) | 3 years |
Acquisition, Goodwill and Acq_5
Acquisition, Goodwill and Acquisition-Related Intangible Assets - Goodwill Rollforward (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |
Jun. 30, 2022 | Mar. 31, 2022 | Jun. 30, 2022 | |
Goodwill [Roll Forward] | |||
Goodwill, Beginning balance | $ 216,915 | $ 188,397 | $ 188,397 |
Additions related to the acquisition completed | 56,530 | 28,518 | |
Measurement period adjustments | 49 | ||
Goodwill, Ending balance | $ 273,494 | $ 216,915 | $ 273,494 |
Acquisition, Goodwill and Acq_6
Acquisition, Goodwill and Acquisition-Related Intangible Assets - Acquisition-Related Intangible Assets (Details) $ in Thousands | 6 Months Ended | |
Jun. 30, 2022 USD ($) | Dec. 31, 2021 USD ($) | |
Finite-lived Intangible Assets [Roll Forward] | ||
Gross Carrying Amount, beginning balance | $ 165,360 | |
Accumulated Amortization, beginning balance | (71,805) | |
Gross Carrying Amount, Additions | 62,300 | |
Accumulated Amortization, Amortization | (15,019) | |
Gross Carrying Amount, ending balance | 227,660 | |
Accumulated Amortization, ending balance | (86,824) | |
Net Carrying Amount | $ 140,836 | $ 93,555 |
Weighted Average Estimated Useful Life (in years) | 5 years 1 month 6 days | |
Developed technology | ||
Finite-lived Intangible Assets [Roll Forward] | ||
Gross Carrying Amount, beginning balance | $ 124,730 | |
Accumulated Amortization, beginning balance | (53,663) | |
Gross Carrying Amount, Additions | 30,200 | |
Accumulated Amortization, Amortization | (11,732) | |
Gross Carrying Amount, ending balance | 154,930 | |
Accumulated Amortization, ending balance | (65,395) | |
Net Carrying Amount | $ 89,535 | 71,067 |
Weighted Average Estimated Useful Life (in years) | 4 years 8 months 12 days | |
Customer relationships | ||
Finite-lived Intangible Assets [Roll Forward] | ||
Gross Carrying Amount, beginning balance | $ 25,920 | |
Accumulated Amortization, beginning balance | (7,899) | |
Gross Carrying Amount, Additions | 28,700 | |
Accumulated Amortization, Amortization | (2,347) | |
Gross Carrying Amount, ending balance | 54,620 | |
Accumulated Amortization, ending balance | (10,246) | |
Net Carrying Amount | $ 44,374 | 18,021 |
Weighted Average Estimated Useful Life (in years) | 6 years 1 month 6 days | |
Trade name | ||
Finite-lived Intangible Assets [Roll Forward] | ||
Gross Carrying Amount, beginning balance | $ 8,990 | |
Accumulated Amortization, beginning balance | (4,693) | |
Gross Carrying Amount, Additions | 3,400 | |
Accumulated Amortization, Amortization | (770) | |
Gross Carrying Amount, ending balance | 12,390 | |
Accumulated Amortization, ending balance | (5,463) | |
Net Carrying Amount | $ 6,927 | 4,297 |
Weighted Average Estimated Useful Life (in years) | 3 years 1 month 6 days | |
Others | ||
Finite-lived Intangible Assets [Roll Forward] | ||
Gross Carrying Amount, beginning balance | $ 5,720 | |
Accumulated Amortization, beginning balance | (5,550) | |
Gross Carrying Amount, Additions | 0 | |
Accumulated Amortization, Amortization | (170) | |
Gross Carrying Amount, ending balance | 5,720 | |
Accumulated Amortization, ending balance | (5,720) | |
Net Carrying Amount | $ 0 | $ 170 |
Weighted Average Estimated Useful Life (in years) | 0 years |
Acquisition, Goodwill and Acq_7
Acquisition, Goodwill and Acquisition-Related Intangible Assets - Future Estimated Amortization Expense (Details) - USD ($) $ in Thousands | Jun. 30, 2022 | Dec. 31, 2021 |
Business Combination and Asset Acquisition [Abstract] | ||
Remainder of 2022 | $ 18,630 | |
2023 | 33,438 | |
2024 | 26,759 | |
2025 | 19,642 | |
2026 | 17,260 | |
Thereafter | 25,107 | |
Net Carrying Amount | $ 140,836 | $ 93,555 |
Commitments and Contingencies (
Commitments and Contingencies (Details) $ in Millions | Mar. 30, 2022 patent | Nov. 25, 2020 patent | Jun. 30, 2022 USD ($) | Dec. 31, 2021 USD ($) |
Long-term Purchase Commitment [Line Items] | ||||
Non-cancellable purchase commitments | $ 4,472.2 | |||
Non-cancellable purchase commitments, due in next twelve months | 2,937.6 | |||
Non-cancelable purchase commitments, due after next twelve months | 1,534.6 | |||
WSOU Investments, LLC | ||||
Long-term Purchase Commitment [Line Items] | ||||
Patents allegedly infringed, number | patent | 3 | |||
Patents found not infringed, number | patent | 1 | |||
Prepaid Expenses and Other Current Assets | ||||
Long-term Purchase Commitment [Line Items] | ||||
Deposits to purchase inventory | $ 100.8 | $ 49.1 |
Stockholders_ Equity and Stoc_3
Stockholders’ Equity and Stock-Based Compensation - Narrative (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | |
Jan. 01, 2022 | Apr. 30, 2019 | Mar. 31, 2022 | Jun. 30, 2022 | Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Authorized amount for stock repurchases | $ 1,000,000,000 | $ 1,000,000,000 | |||
Repurchase authorization period | 3 years | ||||
Remaining authorized repurchase amount | $ 307,200,000 | ||||
Unamortized compensation costs | $ 643,600,000 | ||||
Unamortized compensation costs weighted-average period | 3 years 7 months 6 days | ||||
2014 Equity Incentive Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Number of additional shares authorized for issuance (in shares) | 9,230,434 | ||||
Number of shares available for grant (in shares) | 94,700,000 | ||||
2014 Equity Incentive Plan | Share-based Payment Arrangement, Option | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Percent of shares outstanding to increase number of shares available for grant and issuance | 3% | ||||
Maximum increase of number of shares available for issuance (in shares) | 50,000,000 | ||||
2014 Employee Stock Purchase Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Percent of shares outstanding to increase number of shares available for grant and issuance | 1% | ||||
2014 Employee Stock Purchase Plan | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Number of shares available for grant (in shares) | 10,000,000 | ||||
2014 Employee Stock Purchase Plan | Employee Stock | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Number of additional shares authorized for issuance (in shares) | 3,076,811 | ||||
Shares issued (in shares) | 240,394 | ||||
Weighted-average purchase price (in dollars per share) | $ 48.75 | ||||
Common stock reserved for issuance (in shares) | 20,800,000 |
Stockholders_ Equity and Stoc_4
Stockholders’ Equity and Stock-Based Compensation - Stock Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | |
Jun. 30, 2022 | Jun. 30, 2022 | Jun. 30, 2021 | |
Share-based Payment Arrangement [Abstract] | |||
Aggregate purchase price | $ 483,660 | $ 619,888 | $ 101,355 |
Shares repurchased (in shares) | 5,954 | ||
Average price paid per share (in dollars per share) | $ 104.11 |
Stockholders_ Equity and Stoc_5
Stockholders’ Equity and Stock-Based Compensation - Option Activities (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 6 Months Ended | 12 Months Ended |
Jun. 30, 2022 | Dec. 31, 2021 | |
Number of Shares Underlying Outstanding Options | ||
Outstanding, beginning balance (in shares) | 8,685 | |
Options granted (in shares) | 0 | |
Options exercised (in shares) | (1,230) | |
Options canceled (in shares) | (164) | |
Outstanding, ending balance (in shares) | 7,291 | 8,685 |
Vested and exercisable (in shares) | 6,145 | |
Weighted- Average Exercise Price per Share | ||
Outstanding, beginning balance (in dollars per share) | $ 12.45 | |
Options granted (in dollars per share) | 0 | |
Options exercised (in dollars per share) | 9.17 | |
Options canceled (in dollars per share) | 16.44 | |
Outstanding, ending balance (in dollars per share) | 12.91 | $ 12.45 |
Vested and exercisable (in dollars per share) | $ 10.58 | |
Weighted- Average Remaining Contractual Term (Years) and Aggregate Intrinsic Value | ||
Weighted-average remaining contractual term of stock options outstanding | 2 years 4 months 24 days | 2 years 9 months 18 days |
Weighted-average remaining contractual term of stock options vested and exercisable | 2 years | |
Aggregate intrinsic value of stock options outstanding | $ 589,386 | $ 1,140,369 |
Aggregate intrinsic value of stock options outstanding, vested and exercisable | $ 511,007 |
Stockholders_ Equity and Stoc_6
Stockholders’ Equity and Stock-Based Compensation - Restricted Stock Unit (RSU) Activities (Details) - Restricted Stock Units (RSUs) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 6 Months Ended | 12 Months Ended |
Jun. 30, 2022 | Dec. 31, 2021 | |
Number of Shares | ||
Unvested beginning balance (in shares) | 7,821 | |
RSUs granted (in shares) | 2,873 | |
RSUs vested (in shares) | (1,374) | |
RSUs forfeited/canceled (in shares) | (272) | |
Unvested ending balance (in shares) | 9,048 | 7,821 |
Weighted- Average Grant Date Fair Value Per Share | ||
Unvested beginning balance (in dollars per share) | $ 70.98 | |
RSUs granted (in dollars per share) | 99.57 | |
RSUs vested (in dollars per share) | 63.72 | |
RSUs forfeited/canceled (in dollars per share) | 74.77 | |
Unvested ending balance (in dollars per share) | $ 81.16 | $ 70.98 |
Restricted Stock Unit Activities, Weighted-Average Remaining Contractual Term and Aggregate Intrinsic Value | ||
Unvested, weighted average remaining contractual term (in years) | 1 year 10 months 24 days | 1 year 8 months 12 days |
Unvested, aggregate intrinsic value | $ 848,123 | $ 1,124,229 |
Stockholders_ Equity and Stoc_7
Stockholders’ Equity and Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation | $ 50,224 | $ 44,944 | $ 100,503 | $ 82,497 |
Cost of revenue | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation | 2,312 | 1,796 | 3,621 | 3,196 |
Research and development | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation | 28,449 | 23,139 | 56,025 | 45,121 |
Sales and marketing | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation | 12,827 | 11,368 | 25,936 | 21,453 |
General and administrative | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation | $ 6,636 | $ 8,641 | $ 14,921 | $ 12,727 |
Net Income Per Share - Basic an
Net Income Per Share - Basic and Diluted Net Income Per Share (Details) $ / shares in Units, shares in Thousands, $ in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended | |||
Nov. 30, 2021 | Jun. 30, 2022 USD ($) $ / shares shares | Jun. 30, 2021 USD ($) $ / shares shares | Jun. 30, 2022 USD ($) $ / shares shares | Jun. 30, 2021 USD ($) $ / shares shares | ||
Numerator: | ||||||
Net income | $ | $ 299,099 | $ 196,888 | $ 571,358 | $ 377,254 | ||
Denominator: | ||||||
Weighted-average shares used in computing net income per share, basic (in shares) | [1] | 306,754 | 305,844 | 307,399 | 305,536 | |
Add weighted-average effect of dilutive securities: | ||||||
Stock options and RSUs (in shares) | 9,695 | 12,764 | 10,509 | 12,940 | ||
Employee stock purchase plan (in shares) | 132 | 232 | 132 | 232 | ||
Weighted-average shares used in computing net income per share, diluted (in shares) | [1] | 316,581 | 318,840 | 318,040 | 318,708 | |
Net income per share: | ||||||
Basic (in dollars per share) | $ / shares | [1] | $ 0.98 | $ 0.64 | $ 1.86 | $ 1.23 | |
Diluted (in dollars per share) | $ / shares | [1] | $ 0.94 | $ 0.62 | $ 1.80 | $ 1.18 | |
Stock split ratio | 4 | |||||
[1]Prior periods have been adjusted to reflect the four-for-one stock split effected in the form of a stock dividend in November 2021. |
Net Income Per Share - Antidilu
Net Income Per Share - Antidilutive Securities Excluded from Earnings Per Share (Details) shares in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended | ||
Nov. 30, 2021 | Jun. 30, 2022 shares | Jun. 30, 2021 shares | Jun. 30, 2022 shares | Jun. 30, 2021 shares | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||
Antidilutive securities excluded from earnings per share (in shares) | 781 | 484 | 431 | 520 | |
Stock split ratio | 4 | ||||
Stock options and RSUs | |||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||
Antidilutive securities excluded from earnings per share (in shares) | 781 | 404 | 423 | 460 | |
Employee stock purchase plan | |||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||
Antidilutive securities excluded from earnings per share (in shares) | 0 | 80 | 8 | 60 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | |
Income Tax Disclosure [Abstract] | ||||
Income before income taxes | $ 362,320 | $ 221,084 | $ 671,787 | $ 428,951 |
Provision for income taxes | $ 63,221 | $ 24,196 | $ 100,429 | $ 51,697 |
Effective tax rate | 17.40% | 10.90% | 14.90% | 12.10% |
Geographical Information (Detai
Geographical Information (Details) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2022 USD ($) | Jun. 30, 2021 USD ($) | Jun. 30, 2022 USD ($) segment | Jun. 30, 2021 USD ($) | Dec. 31, 2021 USD ($) | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Number of reportable segments | segment | 1 | ||||
Revenue | $ 1,051,891 | $ 707,319 | $ 1,928,957 | $ 1,374,881 | |
Long-lived assets | 91,823 | 91,823 | $ 78,634 | ||
Americas | |||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Revenue | 845,055 | 514,149 | 1,509,432 | 1,016,021 | |
Europe, Middle East and Africa | |||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Revenue | 104,538 | 112,048 | 239,343 | 208,322 | |
Asia-Pacific | |||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Revenue | 102,298 | $ 81,122 | 180,182 | $ 150,538 | |
United States | |||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Long-lived assets | 70,216 | 70,216 | 62,163 | ||
International | |||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||
Long-lived assets | $ 21,607 | $ 21,607 | $ 16,471 |